Cargando…

A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight

The number of low birthweight (LBW) infants weighing below 2500 g has not decreased in Japan. This study aimed to develop an adult non-obese hyperglycemic mouse model born with LBW to study the pathogenesis. At 16.5 days of gestation, transient intrauterine ischemia (blocked blood flow in both uteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Daichi, Nagano, Nobuhiko, Shimizu, Shoichi, Nakazaki, Kimitaka, Matsuda, Kengo, Tokunaga, Wataru, Fuwa, Kazumasa, Aoki, Ryoji, Morioka, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312481/
https://www.ncbi.nlm.nih.gov/pubmed/35884949
http://dx.doi.org/10.3390/biomedicines10071642
_version_ 1784753851103969280
author Katayama, Daichi
Nagano, Nobuhiko
Shimizu, Shoichi
Nakazaki, Kimitaka
Matsuda, Kengo
Tokunaga, Wataru
Fuwa, Kazumasa
Aoki, Ryoji
Morioka, Ichiro
author_facet Katayama, Daichi
Nagano, Nobuhiko
Shimizu, Shoichi
Nakazaki, Kimitaka
Matsuda, Kengo
Tokunaga, Wataru
Fuwa, Kazumasa
Aoki, Ryoji
Morioka, Ichiro
author_sort Katayama, Daichi
collection PubMed
description The number of low birthweight (LBW) infants weighing below 2500 g has not decreased in Japan. This study aimed to develop an adult non-obese hyperglycemic mouse model born with LBW to study the pathogenesis. At 16.5 days of gestation, transient intrauterine ischemia (blocked blood flow in both uterine arteries for 15 min) was performed in a subgroup of pregnant mice (group I). Non-occluded dams were used as sham controls (group C). After birth, female pups in each group were weaned at 4 weeks of age and reared on the normal diet until 8 weeks of age (n = 7). Fasting blood glucose levels, serum immunoreactive insulin (IRI), and body composition were then measured. Metabolite analyses was performed on the liver tissues. Birthweight was significantly lower in group I compared with group C. Pups from group I remained underweight with low fat-free mass and showed hyperglycemia with high serum IRI and homeostasis model assessment of insulin resistance levels, indicating insulin resistance. Metabolite analyses showed significantly reduced adenosine triphosphate and nicotinamide adenine dinucleotide production and increased lactic acid in group I. The pathogenesis of our non-obese hyperglycemic mouse model may be due to increased myogenic insulin resistance based on mitochondrial dysfunction and reduced lean body mass.
format Online
Article
Text
id pubmed-9312481
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93124812022-07-26 A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight Katayama, Daichi Nagano, Nobuhiko Shimizu, Shoichi Nakazaki, Kimitaka Matsuda, Kengo Tokunaga, Wataru Fuwa, Kazumasa Aoki, Ryoji Morioka, Ichiro Biomedicines Article The number of low birthweight (LBW) infants weighing below 2500 g has not decreased in Japan. This study aimed to develop an adult non-obese hyperglycemic mouse model born with LBW to study the pathogenesis. At 16.5 days of gestation, transient intrauterine ischemia (blocked blood flow in both uterine arteries for 15 min) was performed in a subgroup of pregnant mice (group I). Non-occluded dams were used as sham controls (group C). After birth, female pups in each group were weaned at 4 weeks of age and reared on the normal diet until 8 weeks of age (n = 7). Fasting blood glucose levels, serum immunoreactive insulin (IRI), and body composition were then measured. Metabolite analyses was performed on the liver tissues. Birthweight was significantly lower in group I compared with group C. Pups from group I remained underweight with low fat-free mass and showed hyperglycemia with high serum IRI and homeostasis model assessment of insulin resistance levels, indicating insulin resistance. Metabolite analyses showed significantly reduced adenosine triphosphate and nicotinamide adenine dinucleotide production and increased lactic acid in group I. The pathogenesis of our non-obese hyperglycemic mouse model may be due to increased myogenic insulin resistance based on mitochondrial dysfunction and reduced lean body mass. MDPI 2022-07-08 /pmc/articles/PMC9312481/ /pubmed/35884949 http://dx.doi.org/10.3390/biomedicines10071642 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Katayama, Daichi
Nagano, Nobuhiko
Shimizu, Shoichi
Nakazaki, Kimitaka
Matsuda, Kengo
Tokunaga, Wataru
Fuwa, Kazumasa
Aoki, Ryoji
Morioka, Ichiro
A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
title A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
title_full A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
title_fullStr A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
title_full_unstemmed A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
title_short A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
title_sort non-obese hyperglycemic mouse model that develops after birth with low birthweight
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312481/
https://www.ncbi.nlm.nih.gov/pubmed/35884949
http://dx.doi.org/10.3390/biomedicines10071642
work_keys_str_mv AT katayamadaichi anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT naganonobuhiko anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT shimizushoichi anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT nakazakikimitaka anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT matsudakengo anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT tokunagawataru anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT fuwakazumasa anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT aokiryoji anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT moriokaichiro anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT katayamadaichi nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT naganonobuhiko nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT shimizushoichi nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT nakazakikimitaka nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT matsudakengo nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT tokunagawataru nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT fuwakazumasa nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT aokiryoji nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight
AT moriokaichiro nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight